Christina N Dragon1, Paul Guerino1, Erin Ewald2, Alison M Laffan2. 1. 1 Office of Minority Health, Centers for Medicare & Medicaid Services , Baltimore, Maryland. 2. 2 Health Care Department, NORC at the University of Chicago , Bethesda, Maryland.
Abstract
PURPOSE: Data on the health and well-being of the transgender population are limited. However, using claims data we can identify transgender Medicare beneficiaries (TMBs) with high confidence. We seek to describe the TMB population and provide comparisons of chronic disease burden between TMBs and cisgender Medicare beneficiaries (CMBs), thus laying a foundation for national level TMB health disparity research. METHODS: Using a previously validated claims algorithm based on ICD-9-CM codes relating to transsexualism and gender identity disorder, we identified a cohort of TMBs using Medicare Fee-for-Service (FFS) claims data. We then describe the demographic characteristics and chronic disease burden of TMBs (N = 7454) and CMBs (N = 39,136,229). RESULTS: Compared to CMBs, a greater observed proportion of TMBs are young (under age 65) and Black, although these differences vary by entitlement. Regardless of entitlement, TMBs have more chronic conditions than CMBs, and more TMBs have been diagnosed with asthma, autism spectrum disorder, chronic obstructive pulmonary disease, depression, hepatitis, HIV, schizophrenia, and substance use disorders. TMBs also have higher observed rates of potentially disabling mental health and neurological/chronic pain conditions, as well as obesity and other liver conditions (nonhepatitis), compared to CMBs. CONCLUSION: This is the first systematic look at chronic disease burden in the transgender population using Medicare FFS claims data. We found that TMBs experience multiple chronic conditions at higher rates than CMBs, regardless of Medicare entitlement. TMBs under age 65 show an already heavy chronic disease burden which will only be exacerbated with age.
PURPOSE: Data on the health and well-being of the transgender population are limited. However, using claims data we can identify transgender Medicare beneficiaries (TMBs) with high confidence. We seek to describe the TMB population and provide comparisons of chronic disease burden between TMBs and cisgender Medicare beneficiaries (CMBs), thus laying a foundation for national level TMB health disparity research. METHODS: Using a previously validated claims algorithm based on ICD-9-CM codes relating to transsexualism and gender identity disorder, we identified a cohort of TMBs using Medicare Fee-for-Service (FFS) claims data. We then describe the demographic characteristics and chronic disease burden of TMBs (N = 7454) and CMBs (N = 39,136,229). RESULTS: Compared to CMBs, a greater observed proportion of TMBs are young (under age 65) and Black, although these differences vary by entitlement. Regardless of entitlement, TMBs have more chronic conditions than CMBs, and more TMBs have been diagnosed with asthma, autism spectrum disorder, chronic obstructive pulmonary disease, depression, hepatitis, HIV, schizophrenia, and substance use disorders. TMBs also have higher observed rates of potentially disabling mental health and neurological/chronic pain conditions, as well as obesity and other liver conditions (nonhepatitis), compared to CMBs. CONCLUSION: This is the first systematic look at chronic disease burden in the transgender population using Medicare FFS claims data. We found that TMBs experience multiple chronic conditions at higher rates than CMBs, regardless of Medicare entitlement. TMBs under age 65 show an already heavy chronic disease burden which will only be exacerbated with age.
Authors: Douglas Roblin; Joshua Barzilay; Dennis Tolsma; Brandi Robinson; Laura Schild; Lee Cromwell; Hayley Braun; Rebecca Nash; Joseph Gerth; Enid Hunkeler; Virginia P Quinn; Vin Tangpricha; Michael Goodman Journal: Ann Epidemiol Date: 2016-02-04 Impact factor: 3.797
Authors: Karen I Fredriksen-Goldsen; Loree Cook-Daniels; Hyun-Jun Kim; Elena A Erosheva; Charles A Emlet; Charles P Hoy-Ellis; Jayn Goldsen; Anna Muraco Journal: Gerontologist Date: 2013-03-27
Authors: Albert G Crawford; Christine Cote; Joseph Couto; Mehmet Daskiran; Candace Gunnarsson; Kara Haas; Sara Haas; Somesh C Nigam; Rob Schuette Journal: Popul Health Manag Date: 2010-06 Impact factor: 2.459
Authors: K Wierckx; E Elaut; E Declercq; G Heylens; G De Cuypere; Y Taes; J M Kaufman; G T'Sjoen Journal: Eur J Endocrinol Date: 2013-09-13 Impact factor: 6.664
Authors: Richard A Goodman; Samuel F Posner; Elbert S Huang; Anand K Parekh; Howard K Koh Journal: Prev Chronic Dis Date: 2013-04-25 Impact factor: 2.830
Authors: Dejun Su; Jay A Irwin; Christopher Fisher; Athena Ramos; Megan Kelley; Diana Ariss Rogel Mendoza; Jason D Coleman Journal: Transgend Health Date: 2016-01-01
Authors: Ana M Progovac; Brian O Mullin; Timothy B Creedon; Alex McDowell; Maria Jose Sanchez-Roman; Laura A Hatfield; Mark A Schuster; Benjamin Lê Cook Journal: LGBT Health Date: 2019-08-22 Impact factor: 4.151
Authors: Jeffrey S Becasen; Christa L Denard; Mary M Mullins; Darrel H Higa; Theresa Ann Sipe Journal: Am J Public Health Date: 2018-11-29 Impact factor: 9.308
Authors: Ana M Progovac; Benjamin Lê Cook; Brian O Mullin; Alex McDowell; Maria Jose Sanchez R; Ye Wang; Timothy B Creedon; Mark A Schuster Journal: Health Aff (Millwood) Date: 2018-03 Impact factor: 6.301
Authors: Ana M Progovac; Brian O Mullin; Emilia Dunham; Sari L Reisner; Alex McDowell; Maria Jose Sanchez Roman; Mason Dunn; Cynthia J Telingator; Frederick Q Lu; Aaron Samuel Breslow; Marshall Forstein; Benjamin Lê Cook Journal: Am J Prev Med Date: 2020-03-07 Impact factor: 5.043
Authors: Billy A Caceres; Carl G Streed; Heather L Corliss; Donald M Lloyd-Jones; Phoenix A Matthews; Monica Mukherjee; Tonia Poteat; Nicole Rosendale; Leanna M Ross Journal: Circulation Date: 2020-10-08 Impact factor: 29.690